Compare Indofarma Tbk. (INAF) vs Panca Global Kapital Tbk. (PEGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indofarma Tbk. vs Panca Global Kapital Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Panca Global Kapital Tbk. trades at Rp130 (market cap 487.35B, 11.11M 24h volume). The key difference: Panca Global Kapital Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| INAF | PEGE | |
|---|---|---|
Market Cap | 390.51B | 487.35B |
Volume | — | 11.11M |
Lot | — | 111.15K |
Turnover | — | 1.42B |
Average Price | — | 127.8 |
Value | — | 1.42B |
Indicative Equilibrium Price | — | 130 |
Indicative Equilibrium Volume | — | 1.46K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →About Panca Global Kapital Tbk.
PT Panca Global Securities Tbk. (the Company) was established based on notarial deed No. 20 dated August 13th, 1999 of Fathiah Helmi, S.H., notary in Jakarta. The company's articles of association has been amended several times, and the latest amended on August 30, 2004 concerning company's plan for public offering. The company divides business into 2 divisions, stock brokerage and investment management division.
Read more on PEGE →
